[go: up one dir, main page]

CU23338A3 - XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL - Google Patents

XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL

Info

Publication number
CU23338A3
CU23338A3 CU20040116A CU20040116A CU23338A3 CU 23338 A3 CU23338 A3 CU 23338A3 CU 20040116 A CU20040116 A CU 20040116A CU 20040116 A CU20040116 A CU 20040116A CU 23338 A3 CU23338 A3 CU 23338A3
Authority
CU
Cuba
Prior art keywords
formula
serine proteases
factor inhibitors
proteases involved
compounds
Prior art date
Application number
CU20040116A
Other languages
Spanish (es)
Inventor
Thomas Jeffrey Kohrt
James Kevin Filipski
Huis Alan Chad Van
Agustin Casimiro-Garcia
Franklin Christopher Bigge
Danette Andrea Dudley
Jeremy John Edmunds
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to CU20040116A priority Critical patent/CU23338A3/en
Publication of CU23338A3 publication Critical patent/CU23338A3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona compuestos de fórmula ESPACIO PARA FÓRMULA en la que A,B,C,G y W a la1 tienen cualquiera de los valores definidos en la memoria descriptiva, y sales farmacéuticamente aceptables de los mismos, que son útiles para tratar trastornos trombóticos. También se describen composiciones farmacéuticas que comprenden uno o más compuestos de fórmula I, procedimientos para la preparación de compuestos de fórmula I e intermedios útiles para la preparación de compuestos de fórmula I.The present invention provides compounds of the formula SPACE FOR FORMULA in which A, B, C, G and W at 1 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, which are useful for treating thrombotic disorders. . Also described are pharmaceutical compositions comprising one or more compounds of formula I, processes for the preparation of compounds of formula I and intermediates useful for the preparation of compounds of formula I.

CU20040116A 2004-05-31 2004-05-31 XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL CU23338A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20040116A CU23338A3 (en) 2004-05-31 2004-05-31 XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20040116A CU23338A3 (en) 2004-05-31 2004-05-31 XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL

Publications (1)

Publication Number Publication Date
CU23338A3 true CU23338A3 (en) 2009-01-20

Family

ID=40348308

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20040116A CU23338A3 (en) 2004-05-31 2004-05-31 XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL

Country Status (1)

Country Link
CU (1) CU23338A3 (en)

Similar Documents

Publication Publication Date Title
UY27558A1 (en) INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL
EA200901124A1 (en) COMPOUNDS OF FORMULA (I) AS SERINPROTEASE INHIBITORS
CY1119669T1 (en) DERIVATIVES OF 1-PHENYL-2-PYRIDINYL-ALKYL-ALCOHOL AS PHOSPHOesterase Inhibitors
ATE371656T1 (en) HETEROARYL-PYRIMIDINE DERIVATIVES AS JAK INHIBITORS
DOP2002000422A (en) ANTIBACTERIAL AGENTS.
NO20070532L (en) Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
NO20070557L (en) Phthalazine derivatives as PARP inhibitors
DE602004008098D1 (en) SUBSTITUTED 2H-Ä1,2,4ÜTRIAZOLOÄ4,3-AÜPYRAZINE AS GSK-3 INHIBITORS
CY1111225T1 (en) NEW Peptides As NS3-Serine Protease Inhibitors Inhibit C
NO20070529L (en) Quinazoline dione derivatives as parp inhibitors
EA200900213A1 (en) REVERSE MOTORS
ECSP088099A (en) NEW DERIVATIVES OF 2-AZETIDINONE FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES
ATE554084T1 (en) N-HYDROXYACRYLAMIDE COMPOUNDS
SE0403171D0 (en) New compounds
CY1113175T1 (en) SULFONAMIDIS UNION AND ITS APPLICATION
ECSP044999A (en) ANTIDIABETIC AGENTS
EP1858520A4 (en) QUINAZOLINONE T-TYPE CALCIUM CHANNEL ANTAGONISTS
CY1109975T1 (en) PARA-ALKYL-SUBSTITUTED N-(4-HYDROXY-3-METHOXY-BENZYL) AMIDIA AMINAMIC ACID AND THEIR USE FOR PARASKA
NO20052858L (en) New tricyclic compounds as LTD4 antagonists
EA201001517A1 (en) SUBSTITUTED PIPERIDINES AS THERAPEUTIC COMPOUNDS
AR039937A1 (en) DERIVATIVES OF AZETIDINE AS INHIBITORS OF TRIPSINE PROTEASES
BRPI0409566A (en) phosphonic acid compounds as serine protease inhibitors
CU23338A3 (en) XA FACTOR INHIBITORS AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL
DOP2002000386A (en) ANTIBACTERIAL AGENTS
DE602006020585D1 (en) NEW CYSTONE PROTEASE INHIBITORS AND ITS THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
FD Lapse (for not paying fees)